OBSOLETE: Non-herpetic acute limbic encephalitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:163924
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Non-herpetic acute limbic encephalitis (NHALE) is a term that was historically used to describe a form of acute limbic encephalitis affecting the brain's limbic system — particularly the hippocampus, amygdala, and medial temporal lobes — that is not caused by herpes simplex virus infection. This Orphanet entry (163924) is now classified as OBSOLETE, as the condition has been reclassified and absorbed into broader and more specific diagnostic categories, most notably autoimmune encephalitis. Many cases previously labeled as non-herpetic acute limbic encephalitis are now recognized as autoimmune limbic encephalitis, often associated with specific neuronal antibodies such as anti-NMDA receptor, anti-LGI1, anti-CASPR2, anti-AMPA receptor, or anti-GABA-B receptor antibodies. Some cases are paraneoplastic, occurring in association with underlying malignancies. Patients typically presented with acute or subacute onset of confusion, memory impairment (particularly short-term memory loss), seizures, psychiatric symptoms including personality changes, hallucinations, and behavioral disturbances. MRI often showed signal abnormalities in the medial temporal lobes, and cerebrospinal fluid analysis frequently revealed inflammatory changes. The condition primarily affects the central nervous system. Because this entity has been reclassified, current clinical practice focuses on identifying the specific underlying autoimmune or paraneoplastic etiology. Treatment approaches for autoimmune limbic encephalitis include immunotherapy (corticosteroids, intravenous immunoglobulin, plasma exchange), and second-line agents such as rituximab or cyclophosphamide. When a paraneoplastic cause is identified, treatment of the underlying tumor is essential. Early diagnosis and prompt immunotherapy are associated with better neurological outcomes. Patients suspected of having this condition should be evaluated under current autoimmune encephalitis diagnostic criteria.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Non-herpetic acute limbic encephalitis.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Non-herpetic acute limbic encephalitis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Non-herpetic acute limbic encephalitis community →

No specialists are currently listed for OBSOLETE: Non-herpetic acute limbic encephalitis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Non-herpetic acute limbic encephalitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Non-herpetic acute limbic encephalitisForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Non-herpetic acute limbic encephalitis.

Start the conversation →

Latest news about OBSOLETE: Non-herpetic acute limbic encephalitis

No recent news articles for OBSOLETE: Non-herpetic acute limbic encephalitis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Non-herpetic acute limbic encephalitis

What is OBSOLETE: Non-herpetic acute limbic encephalitis?

Non-herpetic acute limbic encephalitis (NHALE) is a term that was historically used to describe a form of acute limbic encephalitis affecting the brain's limbic system — particularly the hippocampus, amygdala, and medial temporal lobes — that is not caused by herpes simplex virus infection. This Orphanet entry (163924) is now classified as OBSOLETE, as the condition has been reclassified and absorbed into broader and more specific diagnostic categories, most notably autoimmune encephalitis. Many cases previously labeled as non-herpetic acute limbic encephalitis are now recognized as autoimmune